جست‌وجوی استاد و پژوهشگر

Gale Strasburgمشاهده پروفایل

استاد

• Muscle Biology
• Food Safety
• Carcinogen Studies
• +۳ مورد دیگر

Gale Strasburg is a Professor in the Department of Food Science and Human Nutrition at Michigan State University. His research focuses on molecular mechanisms of muscle growth and development, particularly in avian species, and the impact of environmental stressors like thermal challenges on muscle physiology. He is also a leading expert in aflatoxin contamination in agricultural products, including sunflower seeds, and its implications for food safety and human health. Dr. Strasburg holds an M.S. and Ph.D. in Muscle Biology from the University of Wisconsin-Madison, followed by postdoctoral training at the Boston Biomedical Research Institute. His work integrates genomics, cell biology, and food science to address challenges in meat quality, muscle disorders, and mycotoxin mitigation. Research interests include the molecular basis of muscle development, thermal stress effects on satellite cells, and the detection/prevention of aflatoxin in agricultural commodities. His lab has pioneered studies linking aflatoxin in sunflower seeds to liver carcinogenesis, with implications for global food safety. Key trends in his publications (2017–2025) emphasize thermal stress effects on avian muscle cells, genomic responses to environmental challenges, and omics-driven approaches to food safety. He has extensively studied lipid metabolism, signaling pathways (mTOR, Wnt), and RNA regulation in muscle development. Labs/Teams: The Strasburg Laboratory at MSU focuses on interdisciplinary research at the intersection of food science, molecular biology, and agricultural safety. No notable awards or grants are explicitly listed in the provided text.

Karen Steelمشاهده پروفایل

استاد

• Genetics
• Hearing Loss
• Sensory Biology
• +۳ مورد دیگر

Professor Karen Steel is a Professor of Sensory Function at King’s College London, affiliated with the School of Neuroscience and the Department of Genetics within the Institute of Psychiatry, Psychology & Neuroscience. Her research focuses on the genetics of deafness, particularly using mouse models to uncover molecular pathways underlying age-related hearing loss. She leads the Academic Head of Biological Services role and has received prestigious awards, including the Brain Prize (2012) and Fellowship in the Royal Society. Her work bridges basic science and clinical applications, aiming to identify therapeutic targets for hearing loss reversal. Key research interests include genetic mechanisms of hearing impairment, drug development for hearing loss, and translational studies in mouse models. Collaborators include leading institutions globally, such as the Medical University of South Carolina and the University of Sheffield. Notable achievements include reversing hearing loss in mice via gene activation and identifying critical genes like SPNS2 and WBP2. Recent projects include investigations into synaptic damage reversal, genome-wide knockout screens, and the role of microRNAs in auditory function. Her work contributes to Sustainable Development Goals related to health and well-being. Funding sources include Wellcome Trust, Action on Hearing Loss, and NIH.

Vishal Patelمشاهده پروفایل

عضو هیئت علمی

• Chronic Liver Disease
• Gut-Liver Axis
• Microbiome Research
• +۳ مورد دیگر

Vishal Patel is a Clinician Scientist and Principal Investigator at the Institute of Hepatology (Foundation for Liver Research), and an Honorary Clinical Lecturer in the School of Immunology & Microbial Sciences at King's College London. He is also a Consultant Hepatologist & Endoscopist at King's College Hospital NHS Foundation Trust. His primary focus is on translational research in chronic liver disease, particularly the gut-liver axis, microbiome dysbiosis, and systemic inflammation in advanced cirrhosis and acute-on-chronic liver failure (ACLF). He leads the Advanced Chronic Liver Disease (ACLD) research group and has pioneered studies on the role of the gut microbiome in driving infection risk and therapeutic interventions. Education: Bachelor of Medicine and Surgery (MBBS), GSTT Guy's and St Thomas' NHS Foundation Trust (2003) Bachelor of Science (BSc) in Nutrition (First Class), King's College London (2000) PhD in Gut-Liver Axis in Liver Failure Syndromes, King's College London (2020) Research Interests: Dr. Patel's work centers on understanding the pathophysiological roles of the gut microbiome, intestinal barrier dysfunction, and metabolic profiling in ACLD. His group investigates mechanisms linking gut-derived inflammation to systemic complications and develops non-antimicrobial therapies. He has spearheaded clinical trials such as BOPPP (non-selective beta-blockers for variceal prophylaxis) and RIFSYS (Rifaximin in hepatic encephalopathy), and co-leads the Horizon 2020-funded MICROB-PREDICT study. Scientific Awards & Grants: NIHR HTA £2.2M for BOPPP trial NIHR CRN Greenshoots Award Intensive Care Foundation Young Investigator Award Labs & Collaborations: He collaborates with King's Health Partners, European hepatology networks, and global initiatives like the Gut Microbiota for Health Expert Panel. His lab integrates omics approaches (metagenomics, lipidomics) to dissect disease mechanisms and identify biomarkers for ACLF prognosis.

Linda J. Hongمشاهده پروفایل

دانشیار

• Gynecologic Oncology
• Radiation Therapy Techniques
• Clinical Trials
• +۳ مورد دیگر

Linda J. Hong, MD is an Associate Professor in the Department of Gynecology & Obstetrics at Loma Linda University School of Medicine. Her research focuses on radiation oncology techniques, gynecologic malignancies, and clinical trials. She holds an MD from Saint Louis University (2008) and has contributed to over 110 peer-reviewed publications. Her research interests include optimizing radiation therapy methods for breast and gynecologic cancers, exploring genetic testing disparities in underserved populations, and investigating treatment toxicities. Notable projects include studies on dexamethasone regimens for chemotherapy hypersensitivity and surface-guided radiotherapy workflows. Dr. Hong leads or participates in multiple clinical trials, including SWOG-sponsored studies on PARP inhibitors, targeted therapies, and radiation techniques. She collaborates with multidisciplinary teams in radiation oncology, anesthesiology, and global health initiatives. Her work emphasizes patient-centered outcomes, cultural adaptation of medical tools, and improving care equity. Current projects address placenta accreta management, opioid reduction strategies, and environmental factors in gynecologic cancers.

Jason Eriksenمشاهده پروفایل

دانشیار

• Alzheimer's Disease
• Dementia
• Translational Research
• +۳ مورد دیگر

Jason Eriksen is an Associate Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy . He serves as Assistant Dean for Graduate Programs and is an Affiliate Member of the UH Center for Nuclear Receptors . Education: B.S. in Biology and English, Wake Forest University Ph.D. in Neuroscience, Loyola University Chicago Postdoctoral Fellowship, Mayo Clinic Dr. Eriksen's research focuses on Alzheimer's disease and dementia , investigating mechanisms of neurodegeneration and translational approaches for early detection and treatment. His work spans molecular neuroscience, amyloid plaque imaging, and therapeutic development. Scientific Awards: National Academy of Inventors, Senior Member (2020) University of Houston Excellence in Research (2014)

Yvonne Lin-Liuمشاهده پروفایل

استاد بالینی

• Gynecologic Oncology
• Endometrial Cancer
• Ovarian Cancer
• +۳ مورد دیگر

Dr. Yvonne Lin-Liu is a Board Certified Gynecologic Oncologist and Staff Physician in the Division of Gynecologic Oncology within the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco (UCSF). She specializes in treating gynecologic cancers with a patient-centered approach, focusing on helping patients understand their disease biology and available treatment options, particularly serving women seeking second opinions. Dr. Lin-Liu's educational background includes: SB in Chemistry from Massachusetts Institute of Technology (1993) MS in Epidemiology from Harvard School of Public Health (1995) MD from University of California-Irvine College of Medicine (2001) Residency in Obstetrics & Gynecology from Beth Israel Deaconess Medical Center (2005) Fellowship in Gynecologic Oncology from The University of Texas M.D. Anderson Cancer Center (2009) Her research focuses on molecular mechanisms of gynecologic cancers, particularly examining the role of glucose-regulated protein-78 (GRP78), AKT signaling pathways, and the impact of obesity on cellular stress in endometrial cancer development. She has investigated natural compounds like curcumin for cancer treatment and explored the relationship between chronic stress and cancer progression. Her work bridges basic science discoveries with clinical applications to improve patient outcomes. Analysis of her publication record reveals a consistent trajectory in gynecologic oncology research, with emphasis on molecular pathways in endometrial and ovarian cancers. Her work spans from fundamental molecular investigations to clinical studies examining treatment patterns, demonstrating an integrated approach to cancer research that connects laboratory findings with patient care considerations. Dr. Lin-Liu has received significant recognition for her contributions to the field: NIH/NCI Career Development Award (2013) Gynecologic Cancer Foundation/St. Louis Ovarian Cancer Awareness Research Award (2011) Dr. Lin-Liu was previously an NCI-funded physician-scientist at UCSF studying obesity's impact on endometrial cancer before joining Genentech in 2014 as a Group Medical Director. Despite her industry role, she maintains active clinical practice, believing direct patient care is essential to developing effective cancer therapies. She serves on various professional society committees focused on development and editorial boards of prominent journals, demonstrating ongoing commitment to academic medicine. She is an active member of the Society of Gynecologic Oncology, Western Association of Gynecologic Oncologists, American Association for Cancer Research, and American Society of Clinical Oncology, contributing to the broader cancer research community through these professional affiliations.

• Clinical Pharmacology
• Drug Formularies
• Statin-induced Myopathy
• +۴ مورد دیگر

Marie-Louise Ovesjö is an Affiliated Researcher at the Department of Laboratory Medicine, Division of Clinical Pharmacology at Karolinska Institutet in Stockholm, Sweden. She works in affiliation with Karolinska University Hospital, with visiting address at Avd.För klinisk Farmakologi C1:68, Karolinska Universitetssjukhuset, and postal address at H5 Laboratoriemedicin, H5 Klin Farmakologi, 141 52 Huddinge. Her current employment period spans from 2022 to 2025. Her educational background includes: Doctor of Philosophy from the Department of Neuroscience, Karolinska Institutet (2000) University Medical Degree from Karolinska Institutet (1996) Dr. Ovesjö's research demonstrates a dual trajectory spanning both neuropharmacology and clinical pharmacology. Her early work (2000-2003) focused on leptin receptors in the hypothalamus and their role in body weight regulation, investigating GABAergic systems and glutamate transporters. Her more recent research (2009-present) centers on clinical pharmacology applications, particularly the evaluation and implementation of the 'Wise List' - Stockholm's drug and therapeutic committee recommendations for essential medicines. She has conducted extensive research on statin-induced myopathy, exploring vitamin D levels, genetic polymorphisms, and ubiquinone as potential risk factors. Additionally, she has contributed significantly to the development and evaluation of clinical decision support systems, particularly the SFINX drug-drug interaction database. Her publication analysis reveals a consistent focus on improving medication safety and rational drug use in clinical practice. The earlier neuropharmacology work established foundational knowledge about body weight regulation mechanisms, while her clinical pharmacology research has directly influenced medication policy and practice in Stockholm. Her studies on the 'Wise List' demonstrate high adherence rates and physician trust in evidence-based drug recommendations, while her statin research provides valuable insights into managing adverse drug reactions in real-world settings. Dr. Ovesjö has maintained strong collaborative relationships throughout her career, frequently working with the Stockholm Drug and Therapeutic Committee and colleagues across Karolinska Institutet. Her research bridges basic pharmacological science with practical clinical applications, focusing on how healthcare providers and patients interact with medication guidelines and decision support tools.

Konstantinos Kapnisisمشاهده پروفایل

استاد آموزشی

• Biomedical Engineering
• Cardiovascular Biomechanics
• Biomaterials
• +۷ مورد دیگر

Dr. Konstantinos Kapnisis is a Teaching Professor at the Cyprus University of Technology, serving as Lab Manager of the BioLISYS lab. He holds a Diploma in Applied Mathematical and Physical Sciences from the National Technical University of Athens, an MSc from Imperial College London, and a PhD from CUT's Department of Mechanical Engineering and Materials Science and Engineering. His research focuses on biomedical engineering and implant biocompatibility , with expertise in in vivo modeling of cardiovascular and cancer diseases. He specializes in microsurgical procedures in mice and toxicokinetic modeling for implant safety assessments. Developed animal models for implant biocompatibility Advanced PBTK frameworks for cardiovascular devices Investigated stent-induced inflammation and miRNA therapies Scientific Awards: Cyprus State Scholarship Foundation fellowship (2008-2011) A.G. Leventis Foundation scholarship (2011-2013, 2012-2013) Grants: Secured €350,000+ in funding from the Cyprus Research and Innovation Foundation through highly ranked grants including POST-DOC/0916/0237 and INTERNATIONAL/USA/0118/0057.

John N. Buchholzمشاهده پروفایل

استاد

• Cardiovascular Physiology
• Neurophysiology
• Pharmacology
• +۴ مورد دیگر

John N. Buchholz, PhD is a Professor and Vice Chair of the Pharmacology Division within the Basic Sciences department at Loma Linda University School of Medicine. With over three decades of academic service, he maintains an active research program focused on cerebrovascular physiology and pharmacology, particularly examining intracellular calcium signaling mechanisms in endothelium, smooth muscle cells, and vascular sympathetic neurons. Dr. Buchholz's educational background includes a PhD (1989), MS (1984), and BS (1980), all from Loma Linda University. His teaching responsibilities encompass Neuropharmacology (PHRM 554), Cardiovascular & Renal Pharmacology (PHRM 564), and Advanced Physiology & Pathophysiology (PHSL 506). PhD, Loma Linda University (1989) MS, Loma Linda University (1984) BS, Loma Linda University (1980) His research interests span cardiovascular and neurophysiology, with particular focus on intracellular calcium signaling, cerebrovascular function, and the impact of aging on vascular mechanisms. Recent work has increasingly examined the relationship between cerebrovascular function and Alzheimer's Disease, exploring how aging alters cerebrovascular endothelial GPCR and K+ channel function with divergent roles based on biological sex. Analysis of Dr. Buchholz's publication record (64 total publications) reveals a consistent focus on vascular physiology with evolving emphasis from basic calcium signaling mechanisms to age-related cerebrovascular changes and their relationship to neurodegenerative conditions. His work spans molecular, cellular, and systems-level approaches, often employing animal models to examine developmental and aging processes. Dr. Buchholz received the Bernard D Griggs, MD Enowed Pharmacology Award in 2022, recognizing his contributions to the field. Bernard D Griggs, MD Enowed Pharmacology Award (2022) As an active mentor and committee member, Dr. Buchholz has served on numerous institutional committees including the Basic Sciences Administrative Team, Admissions Committee, Academic Review Committee, and Promotions Committee. His grant portfolio includes significant NIH funding, most notably as Co-Investigator on the current project 'Cerebrovascular Endothelial Function During Age-Related Development of Alzheimer's Disease' (2022-2027), and previously as Co-PD/PI on the 'Center for Brain Hemorrhage Research' (2014-2019). Dr. Buchholz maintains active involvement in professional societies including the Associated Societies for Pharmacology and Experimental Therapeutics (ASPET) and the Society for Neuroscience (SFN), and has served on review committees including the American Heart Association Western States Affiliate Cardiovascular Sciences II.

Saied Mirshahidiمشاهده پروفایل

استاد پژوهشی

• Cancer Research
• Oncology
• Molecular Biology
• +۵ مورد دیگر

Saied Mirshahidi, PhD is an Associate Research Professor in the Department of Medicine at Loma Linda University School of Medicine, with an additional appointment in the Microbiology Division of Basic Sciences. His academic career spans over two decades with research focused on cancer biology, molecular mechanisms, and therapeutic approaches across various cancer types. Dr. Mirshahidi's research interests center on cancer biology with particular emphasis on leukemia, thyroid cancer, and health disparities in cancer outcomes. His work explores molecular mechanisms including the Warburg effect in cancer metabolism, immunotherapy approaches, tumor microenvironment interactions, and targeted therapies for specific cancer subtypes. His laboratory investigates how cancer cells reprogram their metabolism and how this can be targeted therapeutically, with significant work on vitamin D's role in modulating cancer cell metabolism. Analysis of his recent publications reveals a strong focus on precision oncology approaches, with particular attention to molecular subtypes of cancer, resistance mechanisms to targeted therapies, and immunometabolism. His work spans from basic molecular mechanisms to clinical applications, with several studies addressing health disparities in cancer outcomes, particularly in minority populations. Dr. Mirshahidi has been involved in multiple research projects including the Federal LLU Center for Health Disparities Research as a Collaborator (2012-2020), Lactic Acidosis research related to cardiac toxicity in lung cancer treatment (2023), and studies on cerebrospinal fluid liquid biopsy for CNS tumor diagnosis (2024). He has served as Principal Investigator on projects examining the effects of local anesthetics on sarcoma and as Co-Investigator on the Adventist Health Study. His laboratory work integrates molecular biology, cell culture techniques, and translational approaches to bridge basic science discoveries with potential clinical applications, particularly in the areas of cancer metabolism and immunotherapy.

• Drug Repositioning
• Transcriptome Analysis
• Epidermolysis Bullosa
• +۳ مورد دیگر

Dr. Sonja Dorfer is a Researcher affiliated with the Department of Dermatology and Allergology, where she leads the Research Program of Molecular Therapy of Genodermatoses. Her primary research explores therapeutic interventions for rare skin disorders through drug repositioning strategies and molecular analysis. She currently serves as Principal Investigator for the project 'Transcriptome-guided drug repurposing for the treatment of aggressive SCCs' (2023-2026). Her research focuses on: Developing miRNA-based diagnostics for squamous cell carcinoma in epidermolysis bullosa patients Repurposing FDA-approved drugs like diacerein for chronic wound management Epigenetic regulation in genodermatoses pathogenesis Biomarker discovery for rare dermatological malignancies She received scientific recognition including the ÖGDV Science Days Poster Price (2024) for contributions to dermatological research. Her publications demonstrate consistent focus on translating molecular findings into clinical applications for epidermolysis bullosa and related carcinomas.

Dawn Colettaمشاهده پروفایل

دانشیار

• Molecular Genetics
• Epigenetics
• Endocrinology
• +۴ مورد دیگر

Dawn Coletta, PhD, is an Associate Professor at the University of Arizona's College of Medicine, with shared appointments in the Division of Endocrinology, Diabetes and Metabolism (Department of Medicine) and the Department of Physiology. She joined the university in 2016 and previously held academic roles at Arizona State University and the University of Texas Health Science Center at San Antonio. Education: PhD from Aston University (Birmingham, UK) Postdoctoral Training: University of Texas Health Science Center at San Antonio Dr. Coletta specializes in the molecular genetics and epigenetics of insulin resistance, a central factor in type 2 diabetes, obesity, and metabolic syndrome. Her lab employs cutting-edge techniques like global epigenetic mapping, DNA chip microarray analysis, and proteome studies to identify susceptibility genes and develop targeted therapies. The 2025-2024 publications highlight her work on cardiometabolic risk factors in Latino populations, exercise-induced epigenetic changes, and genetic interactions in obesity. Her studies often integrate clinical interventions (e.g., bariatric surgery) with molecular profiling to uncover disease mechanisms. Her research has been funded by prestigious organizations including the National Institutes of Health (NIH), American Diabetes Association (ADA), and American Heart Association (AHA). She actively contributes to curriculum development, teaching, and mentoring across multiple academic programs. Dr. Coletta is affiliated with the UA Center for Disparities in Diabetes, Obesity and Metabolism and the Arizona Insulin Resistance Registry. Her work emphasizes population-specific factors in metabolic diseases and translational approaches to improve health outcomes.

• Thoracic Surgery
• Lung Cancer
• Surgical Treatment of Respiratory Diseases
• +۸ مورد دیگر

Professor Ahmet Ferudun Işık is a prominent academician at Gaziantep University Faculty of Medicine , Department of Surgical Medical Sciences and Thoracic Surgery, where he has served since 2013. Previously, he held roles at Yuzuncu Yil University (2000-2005) and Ankara University (1992-1996). His work focuses on thoracic surgery , particularly lung cancer , tracheal stenosis , and pleural diseases . Education: Medical degree from Ankara University Faculty of Medicine (1984-1991), specialization in Thoracic Surgery (1992-1996). His research spans lung cancer , hydatid cysts , traumatic thoracic injuries , and nanoparticle toxicity . Over 119 articles and 116 presentations highlight his contributions to thoracic oncology and surgical innovations . Recent studies include tracheal stenosis outcomes (2024), pleural mesothelioma (2024), and pediatric thoracic surgery (2020). Key themes in his articles include: Lung Cancer : Prognostic factors, surgical techniques, and chemotherapy. Thoracic Trauma : War-related injuries, diaphragmatic ruptures, and diagnostic challenges. Hydatid Disease : Surgical approaches and complications in pediatric cases. Nanoparticle Effects : Toxicological studies on engineered nanoparticles. He has authored two books, including The Red Book of Thoracic Surgery (2015). Collaborations span institutions in Turkey, Japan, and Belgium. No scientific awards are explicitly mentioned, but his high publication count and international conference participation underscore his academic influence.

Mickey Scheinowitzمشاهده پروفایل

استاد

• Exercise Physiology
• Cardiovascular Physiology
• Sports Technology
• +۳ مورد دیگر

Prof. Mickey Scheinowitz serves as Director of the Sylvan Adams Sports Institute at Tel Aviv University within the Iby and Aladar Fleischman Faculty of Engineering's Department of Biomedical Engineering. His research integrates Exercise Physiology , Sports Technology , and Biomechanics to enhance athletic performance and recovery. Current affiliations: Tel Aviv University (Faculty of Engineering, Biomedical Engineering Department) Research domains: Thermal physiology, Anaerobic power prediction, Cycling biomechanics, Fatigue monitoring, Mental-physiological performance interactions Email: mickeys@tauex.tau.ac.il Research Trends in his 2023-2025 publications show: Advancements in dynamic SPECT imaging for cardiovascular diagnostics Development of machine learning algorithms for exercise stress test interpretation Exploration of microbiome-exercise interactions in endurance athletes Innovations in non-invasive temperature monitoring during high-intensity activity Laboratory Operations focus on multi-disciplinary approaches to athletic performance optimization, located in the Multi-disciplinary Center (room 412) with integration of thermal imaging , EMG analysis , and SportsTech innovations .

• Thoracic Surgery
• Robotic Surgery
• Lung Cancer Screening
• +۵ مورد دیگر

Giulia Veronesi is a Full Professor of Thoracic Surgery at Vita-Salute San Raffaele University in Milan and serves as Director of the Thoracic Surgery Division at San Raffaele Hospital. With over 286 publications and an H-index of 49, she is a leading authority in robotic thoracic surgery and lung cancer screening programs. Her career spans both clinical practice and academic research with significant contributions to surgical oncology. Dr. Veronesi earned her Degree in Medicine and Surgery from the University of Milan in 1994, followed by Specialization in Thoracic Surgery from the University of Modena and Reggio Emilia in 2006, and Specialist certification in Digestive System Surgery and Surgical Digestive Endoscopy from the University of Milan in 2000. She further enhanced her expertise with a Master's Degree in Management Training for Managers of Complex Hospital Structures from the SDS School of Healthcare Management (2012). Her professional training includes prestigious institutions such as Mount Sinai School of Medicine, Institute Mutualiste Montsouris in Paris, and Cornell University. Her research focuses on advancing robotic surgical techniques for thoracic procedures, particularly for lung cancer treatment and early detection. She has developed one of Europe's largest lung cancer screening programs using low-dose CT and microRNA testing in high-risk populations. Her work spans minimally invasive surgical techniques, biomarker development, and innovative approaches to thoracic oncology. Recent publications reveal a strong emphasis on robotic surgery applications, early detection methodologies, and molecular diagnostics for lung cancer. Dr. Veronesi's research output demonstrates consistent innovation across multiple fronts of thoracic surgery. Her publications from 2024-2025 show particular focus on refining robotic surgical techniques for complex cases, improving early detection methods, and understanding molecular mechanisms in lung cancer progression. The breadth of her work spans from technical surgical innovations to population-level screening programs. Robert J. Ginsberg Lectureship Award for Surgery (2019) from International Association for the Study of Lung Cancer Women&Technologies Award (2017) from Women&Tech-Associazione Donne e Tecnologie As an educator, Dr. Veronesi has served as a proctor for robotic thoracic surgery across multiple European countries and has held teaching positions at Humanitas University, the University of Milan, and University of Modena. She has secured over €3.5 million in research funding as Principal Investigator, including significant grants from AIRC (€765,000), ERA-NET/CLEARLY project (€1,630,749), and NCI-funded trials. Her research portfolio includes groundbreaking work on lung cancer screening protocols, biomarker validation, and robotic surgical techniques. Dr. Veronesi founded the ESTS Robotic Working Group and serves on multiple editorial boards including Lung Cancer, Annals of Thoracic Surgery, and Journal of Thoracic Disease. She actively leads multidisciplinary teams for thoracic oncology and lung cancer screening at San Raffaele Hospital, integrating surgical, medical, and diagnostic expertise to optimize patient outcomes. Her leadership extends to national committees including the Consiglio Superiore di Sanità.